Blue Trust Inc. Buys 3,993 Shares of Colgate-Palmolive (NYSE:CL)

Blue Trust Inc. increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 314.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 5,263 shares of the company’s stock after buying an additional 3,993 shares during the period. Blue Trust Inc.’s holdings in Colgate-Palmolive were worth $511,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of CL. Fisher Asset Management LLC boosted its holdings in shares of Colgate-Palmolive by 1,010.7% during the 4th quarter. Fisher Asset Management LLC now owns 3,210 shares of the company’s stock worth $256,000 after buying an additional 2,921 shares during the period. Park Avenue Securities LLC raised its stake in Colgate-Palmolive by 20.5% in the 1st quarter. Park Avenue Securities LLC now owns 7,368 shares of the company’s stock worth $663,000 after purchasing an additional 1,252 shares in the last quarter. RFG Advisory LLC raised its stake in Colgate-Palmolive by 6.4% in the 1st quarter. RFG Advisory LLC now owns 5,299 shares of the company’s stock worth $477,000 after purchasing an additional 317 shares in the last quarter. Global Assets Advisory LLC acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $3,505,000. Finally, DGS Capital Management LLC raised its stake in Colgate-Palmolive by 110.1% in the 1st quarter. DGS Capital Management LLC now owns 5,510 shares of the company’s stock worth $496,000 after purchasing an additional 2,888 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of several analyst reports. Bank of America lifted their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Barclays lifted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Sanford C. Bernstein lifted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. UBS Group boosted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, TD Cowen boosted their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $106.00.

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL opened at $99.68 on Wednesday. The firm’s fifty day moving average is $103.38 and its 200-day moving average is $97.83. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a 52 week low of $71.46 and a 52 week high of $109.30. The firm has a market cap of $81.78 billion, a P/E ratio of 31.54, a P/E/G ratio of 3.54 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period in the prior year, the firm posted $0.77 EPS. The company’s quarterly revenue was up 4.9% on a year-over-year basis. Equities analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.01%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock worth $4,486,063 in the last quarter. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.